Check checklists assessing quality of economic evaluations Clinical study 09 February 2019 Pages: 1 - 1
New steps in US to promote development of complex generics Media release 09 February 2019 Pages: 4 - 4
Antibiotics in asthma exacerbation: lack of value, increased costs Clinical study 09 February 2019 Pages: 6 - 6
Aripiprazole augmentation worth it in treatment-resistant depression Clinical study 09 February 2019 Pages: 7 - 7
Avelumab promising cost-effective option for Merkel cell carcinoma Clinical study 09 February 2019 Pages: 8 - 8
Complications increase herpes zoster burden in older adults Clinical study 09 February 2019 Pages: 10 - 10
Effect of GF withdrawal on needle/syringe programme in Mexico Clinical study 09 February 2019 Pages: 14 - 14
Gefitinib, erlotinib preferred in EGFR-mutation+ NSCLC in China Clinical study 09 February 2019 Pages: 15 - 15
IDegLira good value for money in T2DM in Czech Republic Clinical study 09 February 2019 Pages: 17 - 17
Influence of price disclosure in direct-to-consumer advertising Clinical study 09 February 2019 Pages: 18 - 18
Inhaled mannitol cost effective in cystic fibrosis in Australia Clinical study 09 February 2019 Pages: 19 - 19
Nivolumab plus ipilimumab improves QOL versus sunitinib Clinical study 09 February 2019 Pages: 20 - 20
Omalizumab add-on therapy cost effective in severe asthma in Spain Clinical study 09 February 2019 Pages: 21 - 21
Onychomycosis medications: huge cost gap generic vs branded in US Clinical study 09 February 2019 Pages: 22 - 22
Opioid-specific payments to prescribers increases prescribing Clinical study 09 February 2019 Pages: 23 - 23
Oral contraceptives cost effective for endometriosis-related pain Clinical study 09 February 2019 Pages: 24 - 24
Price important barrier to ORS use to treat child diarrhoea in Uganda Clinical study 09 February 2019 Pages: 26 - 26
Production of vaccines in developing countries economical Clinical study 09 February 2019 Pages: 27 - 27
Selective cystoscopy during hysterectomy reduces costs Clinical study 09 February 2019 Pages: 28 - 28
Shift to Medicare Part D may reduce total drug expenditure Clinical study 09 February 2019 Pages: 29 - 29
Teriflunomide more effective, less costly in relapsing MS in China Clinical study 09 February 2019 Pages: 30 - 30
Universal HCV screening of pregnant women cost effective Clinical study 09 February 2019 Pages: 31 - 31
Universal prenatal hepatitis C screening cost effective in USA Clinical study 09 February 2019 Pages: 32 - 32
Tremfya and Ilymya listed for plaque psoriasis in Australia News item 09 February 2019 Pages: 35 - 35